 | • レポートコード：MRC-IM30343 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年49億ドルであった世界の心臓再同期療法（CRT）市場規模が2027年には72億ドルに達し、予測期間中、年平均6.7％成長すると予測しています。本調査レポートでは、心臓再同期療法（CRT）の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（CRT除細動器、CRTペースメーカー）分析、用途別（心室内同期不全、心室間（V-V）同期不全、房室（A-V）同期不全）分析、エンドユーザー別（病院、心臓センター、外来手術センター、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Incなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の心臓再同期療法（CRT）市場規模：種類別 - CRT除細動器の市場規模 - CRTペースメーカーの市場規模 ・世界の心臓再同期療法（CRT）市場規模：用途別 - 心室内同期不全における市場規模 - 心室間（V-V）同期不全における市場規模 - 房室（A-V）同期不全における市場規模 ・世界の心臓再同期療法（CRT）市場規模：エンドユーザー別 - 病院における市場規模 - 心臓センターにおける市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の心臓再同期療法（CRT）市場規模：地域別 - 北米の心臓再同期療法（CRT）市場規模 - アジアの心臓再同期療法（CRT）市場規模 - 欧州の心臓再同期療法（CRT）市場規模 - 中南米の心臓再同期療法（CRT）市場規模 - 中東・アフリカの心臓再同期療法（CRT）市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global cardiac resynchronization therapy (CRT) market size reached US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2027, exhibiting a growth rate (CAGR) of 6.7% during 2022-2027.
Cardiac resynchronization therapy (CRT), or biventricular pacing, refers to a therapeutic procedure to correct or facilitate synchronized beating of the right and left ventricle of the heart. This therapy aids in improving the functioning of the heart, increasing the blood flow and facilitating faster recovery of the patient. It involves the use of a defibrillator to generate a pulse and thin insulated wires or leads to send electric impulses into the lower chambers of the heart. The device is surgically implanted and is connected to an external computer for periodic monitoring of the heart. It sends small electrical impulses to the left and right ventricles to support contraction at the same time.
The increasing prevalence of cardiovascular diseases (CVDs) across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to ailments such as arrhythmias, congenital heart disease and atrial fibrillation, is providing a thrust to the market growth. In line with this, increasing health consciousness and awareness regarding the available treatment alternatives for heart-related ailments is also contributing to the market growth. Various technological advancements, such as the development of MRI-safe and wireless CRT devices, are acting as other growth-inducing factors. These novel systems aid in optimizing CRT programming and multipoint pacing to promote the healthy activity of the heart. Other factors, including increasing healthcare expenditures capacities of the individuals, along with improvements in the healthcare infrastructure, especially in the developing nations, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac resynchronization therapy (CRT) market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
CRT-Defibrillator
CRT-Pacemaker
Breakup by Application:
Intraventricular Dyssynchrony
Interventricular (V-V) Dyssynchrony
Atrioventricular (A-V) Dyssynchrony
Breakup by End User:
Hospitals
Cardiac Centers
Ambulatory Surgery Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, LivaNova Plc, Medico S.p.A., Medtronic Plc, Merit Medical Systems Inc. and MicroPort Scientific Corporation.
Key Questions Answered in This Report:
How has the global cardiac resynchronization therapy (CRT) market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cardiac resynchronization therapy (CRT) market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cardiac resynchronization therapy (CRT) market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cardiac Resynchronization Therapy (CRT) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 CRT-Defibrillator
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 CRT-Pacemaker
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Intraventricular Dyssynchrony
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Interventricular (V-V) Dyssynchrony
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Atrioventricular (A-V) Dyssynchrony
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiac Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Ambulatory Surgery Centers
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Biotronik SE & Co. KG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boston Scientific Corporation
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 LivaNova Plc
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.5 Medico S.p.A.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Medtronic Plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Merit Medical Systems Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 MicroPort Scientific Corporation
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
Figure 2: Global: Cardiac Resynchronization Therapy Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cardiac Resynchronization Therapy Market: Breakup by Type (in %), 2021
Figure 4: Global: Cardiac Resynchronization Therapy Market: Breakup by Application (in %), 2021
Figure 5: Global: Cardiac Resynchronization Therapy Market: Breakup by End User (in %), 2021
Figure 6: Global: Cardiac Resynchronization Therapy Market: Breakup by Region (in %), 2021
Figure 7: Global: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cardiac Resynchronization Therapy (CRT-Defibrillator) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cardiac Resynchronization Therapy (CRT-Pacemaker) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cardiac Resynchronization Therapy (Intraventricular Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cardiac Resynchronization Therapy (Interventricular (V-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cardiac Resynchronization Therapy (Atrioventricular (A-V) Dyssynchrony) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cardiac Resynchronization Therapy (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cardiac Resynchronization Therapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cardiac Resynchronization Therapy (Cardiac Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cardiac Resynchronization Therapy (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cardiac Resynchronization Therapy (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cardiac Resynchronization Therapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: North America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: North America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: United States: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: United States: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Canada: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Canada: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Asia Pacific: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Asia Pacific: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: China: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: China: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Japan: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Japan: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: India: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: India: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: South Korea: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: South Korea: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Australia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Australia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Indonesia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Indonesia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Europe: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Europe: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Germany: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Germany: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: France: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: France: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United Kingdom: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United Kingdom: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Italy: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Italy: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Spain: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Spain: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Russia: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Russia: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Latin America: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Latin America: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Brazil: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Brazil: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Mexico: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Mexico: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Middle East and Africa: Cardiac Resynchronization Therapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Middle East and Africa: Cardiac Resynchronization Therapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Global: Cardiac Resynchronization Therapy (CRT) Industry: SWOT Analysis
Figure 75: Global: Cardiac Resynchronization Therapy (CRT) Industry: Value Chain Analysis
Figure 76: Global: Cardiac Resynchronization Therapy (CRT) Industry: Porter’s Five Forces Analysis